Skip to main content

View full-text article in PMC

. 2022 Dec 12;54(12):2107–2117. doi: 10.1038/s12276-022-00902-0

Table 1.

Differential levels of KDM5A and KDM5B in various cancers.

Cancer Type	KDM5A	KDM5B
Acute myeloid leukemia	Upregulated¹⁰¹	Upregulated⁶⁸
Breast cancer	Upregulated^76,80,100	Upregulated^69,102,103
Bladder cancer	N/A^a	Upregulated¹⁰⁴
Colon cancer	N/A	Upregulated¹⁰⁵
Ewing sarcoma	Upregulated¹⁰⁶	N/A
Gastric cancer	Upregulated¹⁰⁷	Upregulated¹⁰⁸
Glioblastoma	Upregulated^109,110 Downregulated¹¹¹	Upregulated^112,113
Head and neck cancer	Upregulated^114,115	Upregulated^116,117
Hepatocellular carcinoma	Upregulated⁶⁷	Upregulated¹¹⁸
Lung cancer	Upregulated^119,120	Upregulated¹²¹
Melanoma	Downregulated¹²²	Upregulated^123,124
Multiple myeloma	Upregulated¹²⁵	Upregulated⁹⁵
Osteosarcoma	Upregulated¹¹	Upregulated¹²⁶
Ovarian cancer	Upregulated¹²⁷	Upregulated¹²⁸
Pancreas cancer	Upregulated¹²⁹	Upregulated¹³⁰
Prostate cancer	Upregulated^88,93	Upregulated^90,91
Renal carcinoma	Upregulated¹³¹	Upregulated¹³¹

^aN/A not available.